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In severely ill patients low concentrations of the corti-
costeroid binding globulin are typically found; the aim
of this study was to quantify directly free bioactive cor-
tisol concentrations in the sera of postoperative car-
diosurgical patients. Serum samples of 12 consecutive
patients undergoing aortocoronary bypass surgery
taken preoperatively and on the postoperative days 1
to 4 were analyzed. Total serum cortisol was quanti-
fied using liquid chromatography-tandem mass spec-
trometry with an on-line sample extraction system
and tri-deuterated cortisol as the internal standard,
and free serum cortisol was measured after over-night
equilibrium dialysis. Whereas on the first postopera-
tive day, the median total serum cortisol concentration
was approximately two-fold increased compared to
preoperative samples (preoperatively, 245 nmol/l
(interquartile range (IQR) 203–293 nmol/l); first post-
operative day, 512 nmol/l (IQR 410–611 nmol/l)), me-
dian dialyzable free cortisol concentration was almost
seven-fold increased (preoperatively, 14.2 nmol/l (IQR
10.9–20.7 nmol/l); first postoperative day, 98.3 nmol/l
(IQR 81.3–134 nmol/l)). On the fourth postoperative
day, median free cortisol was still significantly in-
creased compared to baseline sampling (p < 0.05),
whereas median total cortisol was not. A median of
5.7% (IQR 5.4–7.0%) of total cortisol was found as free
cortisol on the preoperative day, 21.2% (IQR 18.9–
23.5%) on the first postoperative day and 10.5% (IQR
9.8–14.0%) on the fourth postoperative day. It is con-
cluded that during the postoperative period the free-
to-bound ratio of cortisol is highly variable and that
during the acute phase response direct quantification
of free bioactive cortisol concentrations seems to be
biologically more appropriate than the measurement
of total cortisol concentrations. Clin Chem Lab Med
2003; 41(2):146–151
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Introduction
During acute phase response and in severe illness cor-
tisol is of essential importance for immune modula-
tion, maintenance of homeostasis and for cardiovascu-
lar regulation (1, 2). Increased adrenal secretion of
cortisol under the condition of severe stress – as during
the postoperative period – has long been recognized (3,
4); additionally, recent investigations have demon-
strated profound alterations in the transport of cortisol
during acute phase response, which is characterized by
a decline in the concentration of corticosteroid-binding
globulin (CBG), potentially leading to very high free
serum cortisol concentrations (5–11).
Previous studies addressing bioactive free cortisol
concentrations in severely ill patients mainly relied on
indirect calculations of free serum cortisol concentra-
tions from the concentrations of total cortisol and CBG
(10–13). These predictions, however, have not been
validated by direct measurement of free serum cortisol
in intensive care patients. The aim of this investigation
was therefore to study systematically the concen-
trations of bioactive free cortisol in patients undergo-
ing standardized major cardiac surgery – inducing
extensive acute phase response and systemic inflam-
mation – by use of a newly developed direct equilib-
rium dialysis liquid chromatography-tandem mass
spectrometry (ED-LC-TMS) method and to compare
these results with calculated free serum cortisol and to-
tal serum cortisol concentrations.
Patients and Methods
Patients 
Twelve patients undergoing elective coronary artery bypass
grafting with extracorporeal circulation were prospectively
included into the investigation. Residual serum was used
from samples that were taken for clinically indicated labora-
tory tests between 6.00 and 8.00 a.m. on the preoperative
day and on the first 4 postoperative days. Samples were
stored at –20 °C until analysis. Ten patients were male, two
female, the age ranged from 54 to 81 years (median
68 years); anesthesia was induced with etomidate at doses
of 14 to 20 mg. The study was approved by the Institutional
Review Board.
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Europe, Nivelles, Belgium) in one single batch using kit con-
trol material for quality assurance. Serum albumin and C-re-
active protein (CRP) were measured by routine automated tur-
bidimetric immunoassays (Tina-quant®, Roche Diagnostics,
Mannheim, Germany).
To calculate serum free cortisol concentrations from total
serum cortisol and CBG concentrations, the equation de-
scribed by Coolens et al. (17) was applied:
Free serum cortisol = SQR (Z2+0.0122 × T) – Z
with Z = 0.0167+0.0182 × (C – T),
and C: CBG (µmol/l); T: total cortisol (µmol/l); SQR:
square root
To study the imprecision of the ED-LC-TMS method for the de-
termination of free serum cortisol, 12 aliquots of a normal
serum pool were analyzed within three independent series to
calculate the coefficient of variation.
Statistical methods
The t-test was used to test for statistically significant differ-
ences between results obtained in the preoperative and post-
operative samples (day 1 to 4) , with significance assumed for
p < 0.05.
For method comparison between directly measured and
calculated free serum, cortisol linear regression with Pear-
son’s coefficient of correlation was calculated; additionally, a
bias plot was generated according to Bland and Altman (18)
with the calculation of the mean percentage difference be-
tween the methods.
Results
On the first postoperative day, median total serum cor-
tisol concentration was approximately two-fold in-
creased compared to the preoperative sampling (pre-
operatively, 245 nmol/l (interquartile range (IQR)
203–293 nmol/l); first postoperative day, 512 nmol/l
(IQR 410–611 nmol/l), respectively). On subsequent
days, median cortisol concentration declined, so that
on the fourth postoperative day total serum cortisol
was not significantly increased compared to the preop-
erative day (323 nmol/l (IQR 305–416 nmol/l)). 
Median free cortisol concentration determined by
ED-LC-TMS was almost seven-fold increased on the
first postoperative day compared to baseline sampling
(preoperatively, 14.2 nmol/l (IQR 10.9–20.7 nmol/l); first
postoperative day, 98.3 nmol/l (IQR 81.3–134 nmol/l)).
In contrast to total serum cortisol, free serum cortisol
was still significantly increased on the fourth postoper-
ative day (33.9 nmol/l (IQR 28.7–57.9 nmol/l; p < 0.05)
compared to the preoperative sampling. 
The perioperative free-to-bound ratio of cortisol was
highly variable with a median of 5.7% (IQR 5.4–7.0%) of
total cortisol found as free cortisol on the preoperative
day, 21.2% (IQR 18.9–23.5%) on the first postoperative
day and 10.5% (IQR 9.8–14.0%) on the fourth postoper-
ative day (p < 0.05). 
The median concentration of CBG found on the first
postoperative day was 53% of the median concentra-
tion found preoperatively; the median concentration
remained significantly decreased until the fourth post-
Analytical methods
Serum cortisol and cortisone were determined simultane-
ously as described previously (14, 15) using liquid chromato-
graphy-electrospray tandem mass spectrometry. In brief,
samples and calibrators were precipitated with methanol/zinc
sulfate containing tri-deuterated cortisol as the internal stan-
dard (Cambridge Isotope Laboratories, Andover, USA). After
centrifugation, the supernatants were applied to on-line solid-
phase extraction with subsequent HPLC separation employ-
ing column switching (extraction column: Waters Oasis HLB
(Waters, Milford, USA)), washed with 5% methanol, elution in
back-flush with methanol/2 mmol/l ammonium acetate 7/3 by
volume onto an analytical C18-HPLC column (Reprosil pur
C18-AQ, 125 × 2 mm; 5 µm; Maisch, Ammerbuch, Germany).
The HPLC system was coupled to a Micromass Quattro LC
tandem mass spectrometer (Micromass, Manchester, UK) run
in multiple reaction monitoring mode; the following transi-
tions generated by collision induced disintegration of the re-
spective [M+H] ions were monitored: cortisol 363>309 m/z;
d3-cortisol 366>312 m/z. All study samples were analyzed
within two runs. 
Equilibrium dialysis cells were prepared according to
Reinard and Jacobsen (16) from commercially available 1.5 ml
polypropylene microtubes (Eppendorf, Germany; Figure 1).
Lids of these tubes were cut off, placed upside down so that
their recess functioned as a reservoir for approximately 240 µl
of a dialysis buffer (Nichols Dialysis Buffer). A dialysis mem-
brane (regenerated cellulose, molecular weight cut-off
4000–6000 Da; Roth GmbH, Karlsruhe, Germany) was condi-
tioned by first soaking in a large volume of 10 mmol/l sodium
bicarbonate at 60 °C for 1 h while stirring and subsequently by
soaking in distilled water at the same temperature, again for
1 h. After final washing in a large volume of distilled water, the
membrane was cut into 1.5 × 1.5 cm squares to be placed on
the tube lids filled with the dialysis buffer. Tubes were then
placed upside down on top of the lids, thereby fixing the dia-
lysis membranes. Finally the tips of the tubes were cut off to
allow 1 ml of serum to flow into the dialysis cells. 
The cells were incubated for 16 h on a reciprocal shaker
placed in a thermostated oven at 37 °C (± 0.1 °C). After incuba-
tion, the serum-containing tubes were removed and the
dialysate was collected from the lids to be analyzed by liquid
chromatography-tandem mass spectrometry in the same way
as serum samples. 
For quality control of total cortisol measurement commer-
cially available materials were used (Lyphochek Immunoas-
say Plus, Biorad, Hercules, USA).
Serum CBG was quantified by a coated tube RIA (BioSource
Figure 1 The assembly of the equilibrium dialysis cell for the
determination of free cortisol by liquid chromatography-tan-
dem mass spectrometry.
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operative day reaching 68% of the preoperative con-
centration at the end of the observation period. Median
serum albumin concentrations were also significantly
lower on all postoperative days compared to the pre-
operative concentrations. The median CRP concentra-
tion peaked on the second postoperative day with
190 mg/l (IQR 154–233 mg/l). The raw data of the re-
spective analyses are given in Table 1.
Comparison of free serum cortisol concentrations
both measured directly by ED-LC-TMS and calculated
according to Coolens et al. (17) by regression analysis
resulted in the following equation:
[calculated free cortisol] = [free cortisol by
ED-LC-TMS] × 0.78+4.1 nmol/l
with a Pearson’s coefficient of correlation 0.95.
The method comparison according to Bland and Alt-
man (18) demonstrated a mean percentage difference
between the two methods ([free cortisol by ED-LC-
TMS] – [calculated free cortisol]) of 13.2% (standard de-
viation 21.2%) with the differences ranging from
–41.5% to +75%; the respective bias plot is given in Fig-
ure 2.
An interassay coefficient of variation of 8.1% was
observed for the free serum cortisol measurement by
ED-LC-TMS(mean concentration 12.1 nmol/l, n = 12 in
three series).
Discussion
In this investigation, free bioactive serum cortisol con-
centrations were measured directly by use of ED-LC-
TMS in sera of postoperative cardiac intensive care pa-
tients; it was found that free cortisol concentrations
demonstrated a substantially more pronounced dy-
namics during the postoperative acute phase response
compared to total cortisol. Whereas the median total
cortisol concentration was increased about two-fold on
the first postoperative day compared to the preopera-
tive day, median free bioactive cortisol increased
nearly seven-fold. At the end of the investigation pe-
riod median free serum cortisol was still significantly
increased compared to the preoperative sampling
(139% above baseline), whereas at this time point me-
dian total cortisol concentration was only slightly and
–1 POD 1 POD 2 POD 3 POD 4
Total cortisol nmol/l 245.0 512.0* 454.0* 386.0* 323.0
(203–293) (410–611) (348–517) (322–458) (305–416)
Free cortisol by nmol/l 14.2 98.3* 78.7* 68.2* 33.9*
ED-LC-TMS (10.9–20.7) (81.3–134.5) (46.1–101.4) (38.5–74.3) (28.7–57.9)
% free cortisol % 5.7 21.2* 16.0* 15.4* 10.5*
(5.4–7.0) (18.9–23.5) (12.8–19.9)* (12.8–16.9) (9.8–14.0)
Calculated free nmol/l 14.1 78.4* 55.2* 44.2* 31.1*
cortisol (11.2–21.6) (62.3–113) (43.9–79.2) (33.8–63.9) (26.0–45.5)
CBG nmol/l 736.0 392.0* 425.0* 478.0* 503.0*
(587–800) (366–431) (368–463) (406–518) (466–532)
Albumin g/l 48.0 27.0* 28.0* 26.0* 28.0*
(47–49) (24–29) (23–30) (25–30) (27–30)
CRP mg/l <5 67.0* 189.0* 167.0* 116.0*
(<5–<5) (59–92) (153–233) (142–194) (80–120)
1Median and interquartile ranges; POD, postoperative day; *denotes statistically significant differences of the 
respective parameter with regard to the preoperative day.
Table 1 Perioperative concentrations of total serum cortisol
and free serum cortisol determined by equilibrium dialysis
liquid chromatography-tandem mass spectrometry (ED-LC-
TMS), calculated free serum cortisol, corticosteroid-binding
globulin (CBG), albumin, C-reacitve protein (CRP), and the
percentage of free cortisol of total cortisol in 12 patients un-
dergoing coronary bypass surgery1. 
Figure 2 Bias plot according to Bland and Altman (18) of free
serum cortisol concentrations determined directly by equilib-
rium dialysis liquid chromatography-tandem mass spectrom-
etry and calculated from the concentrations of total serum
cortisol and corticosteroid-binding globulin.
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not significantly higher than the median preoperative
concentration (31% above baseline). These results cor-
respond to a substantial increase in the ratio of free-to-
total cortisol from 5.7% preoperatively to as much as
21.2% on the first postoperative day.
Since in general only the free hormone fraction is con-
sidered to be biologically active (19, 20), our data sug-
gest that during the acute phase response free serum
cortisol measurement is biologically more appropriate
compared to the measurement of total cortisol. We de-
cided to study cortisol protein binding during acute
phase response in patients undergoing elective cardiac
bypass surgery with extracorporeal circulation because
this well standardized procedure induces extensive
stress and systemic inflammatory response (as demon-
strated by very high CRP concentrations), and individual
baseline samples can be taken in a non-stressed state
before the patient is transferred to intensive care; this is
not the case, for example, in a heterogeneous popula-
tion of intensive care patients with septic shock.
The observation of very high free serum cortisol con-
centrations and an increased free-to-bound ratio of cor-
tisol in the postoperative period after cardiac surgery is
qualitatively in accordance with previous investiga-
tions, where calculations were applied to estimate free
cortisol concentrations (10, 11). Except for one study
on burn patients (9), studies addressing bioactive corti-
sol in severely ill patients have so far relied on calcula-
tions based on the concentrations of total serum corti-
sol and CBG, respectively (10–13); these calculations,
however, have not been so far validated by comparison
with directly measured free serum cortisol in intensive
care patients. 
The simplest approach to estimate free serum corti-
sol is the calculation of a [cortisol]/[CBG] ratio as a “free
cortisol index” (13, 21). The algorithm described by
Coolens et al. (17) applied in other studies (10, 12) takes
into account the binding characteristics of CBG and is
applicable by use of standard spreadsheet software;
this calculation, however, is simplified in that the con-
centration of albumin and sexhormone-binding globu-
lin (as other important cortisol-binding proteins), and
competing steroids as cortisone are not incorporated.
Conclusive calculation of free serum cortisol concentra-
tions taking into account the latter variables, however,
is not generally applicable, since it leads to complex
equations which have to be solved by numeric proce-
dures for which no software is commercially available
(11, 19, 22). Interestingly, calculations that incorporate
the binding characteristics of CBG and cortisol – both in
a simplified form (17) and by computer simulation (22) –
predict a non-linear rise in bioactive free serum cortisol
with increasing total serum cortisol concentrations,
even at constant CBG concentrations and within the
physiological range of circadian variation of cortisol
concentrations; a simple “free cortisol index” (13, 21)
fails to display this and should not be used.
By linear regression analysis we found an apparently
close correlation between free serum cortisol concen-
trations calculated according to Coolens et al. (17) and
free cortisol measured directly by ED-LC-TMS, with a
coefficient of correlation of 0.95. Bias analysis accord-
ing to Bland and Altman (18), however, demonstrated
poor commutability of the results for individual sam-
ples, an important mean percentage difference of
13.2%, and individual differences of up to 75% between
both methods of free cortisol determination. This rele-
vant bias between calculated and measured free corti-
sol concentrations observed in samples of intensive
care patients may arise from changes in the binding
properties of CBG known to occur in acute phase re-
sponse (6, 23) or from compounds that interfere with
cortisol protein binding, such as free fatty acids (24). 
The technique of ED-LC-TMS developed for our
study proved precise, convenient and applicable to
large studies. Free hormone determination after equi-
librium dialysis without dilution may be regarded as
the highest attainable standard for this purpose (20). In
the less laborious (but more expensive) technique of
ultracentrifugation (17, 25), protein concentration on
the filtration membranes with local volume compres-
sion effects can affect hormone binding. Dialysis with
dilution by a large volume of dialysis buffer can poten-
tially alter the physiological free-to-bound equilibrium
since the distribution volume of cortisol is largely
increased, whereas the sample volume remains un-
changed. For the quantification of cortisol in the ob-
tained dialysate or filtrate, conventional HPLC tech-
niques or immunoassays, as applied so far (25, 26), lack
sensitivity (with detection limits typically above
10 nmol/l) and specificity (with respect to cortisone and
cortisol conjugate metabolites), whereas tandem mass
spectrometry as applied in our investigation proved
highly precise and specific (14).
CBG is a 52 kDa glycoprotein that exhibits structural
homology to serine protease inhibitors (27–30). Low
concentrations of CBG found after major surgery may
be explained by several mechanisms: (i) the negative
acute phase behavior of CBG with decreased synthesis
in response to inflammatory mediators (31–33), (ii) the
conformational changes and active depletion of CBG
(8, 23, 30), and (iii) the in vivo serum dilution following
substantial blood loss and fluid replacement. This lat-
ter dilution effect was suggested in our and and in a
previous investigation (11) by the markedly decreased
concentrations of serum albumin during the postoper-
ative period.
Besides alterations in cortisol binding, other changes
in the hypothalamic-pituitary-adrenal axis in severe ill-
ness have been recognized, such as an increased
adrenal sensivity towards ACTH (4, 34, 35), a continuous
rather than pulsatile pattern of cortisol section (3), and
changes in the number and sensitivity of glucocorticoid
receptors (36, 37). Recently we were able to demon-
strate substantial changes in the peripheral metabolism
of cortisol during acute phase response (38) with a sig-
nificant shift of the systemic set-point from inactive cor-
tisone towards active cortisol. This shift can be ex-
plained by increased activity of 11β-hydroxysteroid
dehydrogenase type I that is mainly expressed in liver
tissue regenerating inactive cortisone to active cortisol
(39, 40). The latter mechanism, as well as the out-of-pro-
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portion increase in bioactive free cortisol observed in
the present study lead to enhanced bioavailability of
cortisol in addition to a mere increase in adrenal cortisol
synthesis during acute phase response. 
Despite these general mechanisms to increase ac-
tive cortisol concentrations in acute phase response, it
has been recognized that in patients with septic shock
relative glucocorticoid deficiency arises frequently (1,
41). This relative adrenal failure can be verified by stim-
ulation testing with exogenous ACTH; respective cut-
off values have been demonstrated to be of prognostic
significance (42) and are used to guide low-dose corti-
sol substitution (1, 41). It is evident from this back-
ground that cortisol measurement will gain impor-
tance in intensive care medicine. Since the alterations
of CBG and albumin concentrations are variable
among severely ill patients and the dynamics of free
serum cortisol is quite different from that of total serum
cortisol in critically ill patients, as shown in the present
investigation, cut-off values for therapeutic decisions
in intensive care medicine might be based on the mea-
surement of free bioactive cortisol rather than on total
cortisol. Therefore, the development of immunoassays
for quantification of free serum cortisol in a routine
clinical setting – by analogy to the measurement of free
thyroid hormones – seems reasonable; the technique
of ED-LC-TMS developed for our study may serve as a
candidate reference method for this purpose.
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